bioAffinity Technologies, Inc. Payments of Debt Issuance Costs
bioAffinity Technologies, Inc. (BIAF) reported Payments of Debt Issuance Costs of $55.65 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2024-04-01.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfDebtIssuanceCosts · last filed 2024-04-01
- bioAffinity Technologies, Inc. payments of debt issuance costs for the quarter ending 2022-12-31 was $0.00.
- bioAffinity Technologies, Inc. payments of debt issuance costs for the quarter ending 2022-09-30 was $0.00.
- bioAffinity Technologies, Inc. payments of debt issuance costs for the quarter ending 2022-06-30 was $0.00.
- bioAffinity Technologies, Inc. payments of debt issuance costs for the quarter ending 2022-03-31 was $55.65K.
- bioAffinity Technologies, Inc. payments of debt issuance costs for fiscal 2022 was $55.65K, a 69.21% decline from fiscal 2021.
- bioAffinity Technologies, Inc. payments of debt issuance costs for fiscal 2021 was $180.75K.
| Period end | Payments of Debt Issuance Costs 3 month | Payments of Debt Issuance Costs 6 month | Payments of Debt Issuance Costs 9 month | Payments of Debt Issuance Costs 12 month |
|---|---|---|---|---|
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $0.00 derived: sum of 2 quarters · filed 2024-04-01 | $0.00 derived: sum of 3 quarters · filed 2024-04-01 | $55.65K 10-K · filed 2024-04-01 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $0.00 derived: sum of 2 quarters · filed 2023-11-14 | $55.65K 10-Q · filed 2023-11-14 | |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $55.65K 10-Q · filed 2023-08-14 | ||
| 2022-03-31 | $55.65K 10-Q · filed 2023-05-15 | |||
| 2021-12-31 | $180.75K 10-K · filed 2023-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |